Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
03/2009
03/25/2009EP2037739A2 Benzyl-substituted quinolone m1 receptor positive allosteric modulators
03/25/2009EP1610790A4 Anticancer compounds
03/25/2009EP1472228B1 Process for the manufacture of hmg-coa reductase inhibitors
03/25/2009CN101395137A Substituted 2-amino-4-phenyl-dhydroquinolines, method for the production thereof, use thereof as medicaments, and medicaments containing them
03/25/2009CN101395106A Dibenzoanthracene compound and organic light emitting device having the same
03/25/2009CN101391980A Method for preparing 6-hydroxyl-3,4dihydro-2(1H)-quinolinone
03/25/2009CN100471842C Quinolone derivative or its salt
03/25/2009CN100471841C (2-carboxamido) (3-amino) thiophene compounds
03/24/2009US7507828 Such as quinoline-8-carboxylic acid [5-(2-mercapto-acetylamino)-pentyl]-amide; increasing sensitivity of cancer cells to radiotherapy cytotoxic effects; neurological diseases
03/24/2009US7507823 Water is introduced to a stream of supercritical fluid which is then allowed to mix with a stream including a mixture including aripiprazole and a solvent; mixing results in the substantially simultaneous dispersion and extraction of the aripiprazole from the mixture by the supercritical fluid
03/24/2009US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity
03/24/2009US7507749 Antitumor agents
03/24/2009US7507732 6,7-Dihydro-5H-cyclopenta[b]pyridine and 5,6,7,8-tetrahydroquinoline compounds; 5-HT2c receptor agonists; to treat diseases like obesity, depression, atypical depression, anxiety, epilepsy, lower urinary tract dysfunction; less toxic; selectivity
03/24/2009CA2431100C Dihydroindole and tetrahydroquinoline derivatives
03/19/2009WO2009036161A1 Process and intermediates for preparing integrase inhibitors
03/19/2009WO2009035951A2 Soluble epoxide hydrolase inhibitors
03/19/2009WO2009035662A1 Deuterated 4 -oxoquinoline derivatives for the treatment of hiv infection
03/19/2009WO2008135886A3 Quinoline derivatives for use in the inhibition of the growth of tumour cells
03/19/2009WO2008032099A3 Process for the preparation of montelukast, and intermediates therefor
03/19/2009WO2005076861A3 Compounds that inhibit hiv particle formation
03/19/2009US20090076271 Process for preparing intermediates of HMG-CoA reductase inhibitors
03/19/2009US20090076077 Methods and Compositions for Selectin Inhibition
03/19/2009US20090076076 Inhibitors of cysteine proteases and methods of use thereof
03/19/2009US20090076073 Therapeutic amides
03/19/2009US20090076072 Deuterium-enriched tafenoquine
03/19/2009US20090075978 Substituted propiolic acid amides and their use for producing drugs
03/19/2009US20090075975 Arylsulfonamides and uses related thereto
03/19/2009US20090074746 Compounds to treat alzheimer's disease
03/19/2009CA2698825A1 Deuterated 4 -oxoquinoline derivatives for the treatment of hiv infection
03/19/2009CA2698245A1 Process and intermediates for preparing integrase inhibitors
03/18/2009EP2036557A1 Antitumor agent for thyroid cancer
03/18/2009EP2035384A2 Process for synthesizing piperazine-piperidine compounds
03/18/2009EP2000137A9 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
03/18/2009EP1689380A4 Method for treating adamts-5-associated disease
03/18/2009CN101386593A Norfloxacin glutamate hydrate and preparation and use thereof
03/18/2009CN101386592A Method for preparing pitavastatin calcium raw material medicine using asymmetric hydrogenation
03/17/2009US7504512 BCL-X1 protein inhibitors; anticarcinogenic agents
03/17/2009US7504508 PGD2 receptor antagonists for the treatment of inflammatory diseases
03/17/2009US7504506 Therapeutic compounds and uses thereof
03/17/2009US7504504 Methods of preparing aripiprazole crystalline forms
03/17/2009US7504437 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants
03/17/2009US7504436 Bioisosteres of actinonin
03/17/2009US7504416 4-substituted quinolines as antitumor agents
03/17/2009US7504415 Therapeutic agent for glomerular disease
03/17/2009US7504393 Benzylamine analogues
03/17/2009CA2412161C Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
03/17/2009CA2316351C Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity
03/17/2009CA2179407C Process for the preparation of leukotriene antagonists
03/12/2009WO2009031705A1 PHARMACEUTICAL COMPOSITION FOR INHIBITING ACCUMULATION OF AMYLOID-β PROTEIN
03/12/2009WO2009030715A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
03/12/2009WO2009030469A1 Fungicidal 2-alkylthio-2-quinolinyloxy-acetamide deritvatives
03/12/2009WO2009030467A2 Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides
03/12/2009US20090069564 Methods and Compositions for Selectin Inhibition
03/12/2009US20090069373 Quinoline Acids
03/12/2009US20090069338 Method for predicting skin sensitizing activity of compounds
03/12/2009US20090069316 Novel quinoline derivatives
03/12/2009US20090069282 Alkyne compounds with mch antagonistic activity and medicaments comprising these compounds
03/12/2009CA2698665A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation
03/12/2009CA2698486A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
03/12/2009CA2696942A1 Fungicidal 2-alkylthio-2-quinolinyloxy-acetamide derivatives
03/12/2009CA2696320A1 Novel fungicides
03/11/2009EP2034000A2 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
03/11/2009EP2033954A1 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as hiv integrase inhibitor
03/11/2009EP2033953A1 Vanilloid receptor modulators
03/11/2009EP2033952A1 Nitrogen-containing Heteroaryl compounds having HIV Integrase Inhibitory Activity
03/11/2009EP2032538A2 Quinoline compounds and methods of use
03/11/2009EP1879580B1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
03/11/2009EP1694689B1 Monocyclopentadienyl complexes
03/11/2009EP1631533B1 Novel process for stereoselective reduction of beta-ketoesters
03/11/2009EP1566385B1 Phosphorescent compound and electroluminescent element including the same
03/11/2009CN101381345A Tetrahydroquinoline derivatives and a process for preparing the same
03/11/2009CN101381344A Preparation method of 2-cyclopropyl-4-(4'-fluorophenyl)quinoline-3-methanol
03/11/2009CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same
03/10/2009US7501517 Process for making montelukast and intermediates therefor
03/10/2009US7501516 3-Cyanoquinolines 4-substituted by a methylenedioxyphenyl group that is attached by a methylene, oxy, thio, sulfinyl, sulfonyl or amino group; antitumor agents
03/10/2009US7501386 Lubricants for automotive and truck crankcase lubricants; as well as transmission lubricants, gear lubricants, hydraulic fluids, compressor oils, diesel and marine lubricants; superior oxidation inhibition; Phenyl-(1,2,3,4-tetrahydro-quinolin-6-yl)-amine, diphenylamine
03/05/2009WO2009029617A1 Diarylamine-substituted quinolones useful as inducible nitric oxide synthase inhibitors
03/05/2009WO2009027990A1 Salts of montelukast and process therefor
03/05/2009WO2009027730A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
03/05/2009US20090062530 Substituted arylalkanoic acid derivatives and use thereof
03/05/2009US20090062284 Thio-Substituted Biarylmethanesulfinyl Derivatives
03/05/2009US20090062280 Ophthalmic Compositions for Treating Ocular Hypertension
03/05/2009US20090062279 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
03/05/2009CA2697971A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
03/05/2009CA2695503A1 Tsh receptor antagonizing tetrahydroquinoline compounds
03/04/2009EP2029596A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same
03/04/2009EP2029544A1 Pyrrolidine derivatives useful as bace inhibitors
03/04/2009EP2028938A1 3,4-disubstituted coumarin and quinolone compounds
03/04/2009EP1776343B1 Quinoline derivatives as neurokinin receptor antagonists
03/04/2009CN100465158C An amino-substituted ethylamino beta2- adrenergic receptor agonist
03/03/2009US7498442 Quinolinone-carboxamide compounds
03/03/2009US7498343 Mycobacterial inhibitors
03/03/2009US7498323 Spiro-piperidine compounds and medicinal use thereof
02/2009
02/26/2009WO2009026408A1 Therapeutic quinoline and naphthalene derivatives
02/26/2009WO2009025265A1 Piperazine derivative
02/26/2009WO2009025160A1 Transition metal complex and process for producing conjugated aromatic compound with the transition metal complex
02/26/2009WO2009024611A2 4-benzylaminoquinolines, pharmaceutical compositions containing them and their use
02/26/2009WO2009024095A1 Method of making and administering quinoline derivatives as anti-cancer agents
02/26/2009WO2008154402A3 Hdac inhibitors and hormone targeted drugs for the treatment of cancer
02/26/2009US20090054653 Enantioselektive preparation of quinoline derivative
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 277